FOR IMMEDIATE RELEASE

CONTACT:    Michele Howard

                        770-441-2051

Immucor to Present at Upcoming Investor Conferences

NORCROSS, Ga., September 8, 2009 - Immucor, Inc. (Nasdaq: BLUD), a global leader in providing automated instrument-reagent systems to the blood transfusion industry, today announced that it will webcast its presentations at two upcoming investor conferences.

Immucor will present at the Robert W. Baird & Co. 2009 Healthcare Conference in New York, NY on Thursday, September 10, 2009 at 12:15 pm Eastern Time. Immucor will also present at the UBS Global Life Sciences Conference in New York, NY on Tuesday, September 22, 2009 at 10:30 am Eastern Time.

Both presentations will be available via a live, simultaneous webcast. Access to the presentations will be available through the "About Us - Investor Information" section at www.immucor.com. For those unable to listen to the live broadcast, a replay of the presentation will be available shortly after its completion and will be archived on Immucor's website for approximately 60 days.

About Immucor

Founded in 1982, Immucor manufactures and sells a complete line of reagents and systems used by hospitals, reference laboratories and donor centers to detect and identify certain properties of the cell and serum components of blood prior to transfusion. Immucor markets a complete family of automated instrumentation for all of its market segments. For more information on Immucor, please visit our website at www.immucor.com.